Lataa...
Will breast cancer chemoprevention stand on ‘solid bone’?
[Image: see text] Aromatase inhibitors are the most effective agents for preventing breast cancer; however, their use is associated with bone loss and an increased risk of fractures. Sestak and colleagues show that administration of an oral bisphosphonate prevents aromatase-inhibitor-induced bone lo...
Tallennettuna:
| Julkaisussa: | Nat Rev Endocrinol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4334702/ https://ncbi.nlm.nih.gov/pubmed/25511313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrendo.2014.220 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|